Drugs / Wosulin 70N/30R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01358435 | Jan → May 2011 | diabetes mellitus | Wockhardt | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wosulin 70N/30R | “between Wosulin 70N/30R and Novolin 70/30.” NCT01358435 ↗ |
| Modality | Protein / enzyme biologic | “Wosulin 70N /30R is a recombinant Human Insulin” NCT01358435 ↗ |
| Route | Subcutaneous | “given subcutaneously” NCT01358435 ↗ |